Skip to main content

We narrowed to 307 results for: Psd

Showing: 1 - 30 of 307 results
  1. pSDMA57

    Plasmid
    #67941
    Purpose
    Complementation in Cryptococcus neoformans. Targets DNA constructs to a Safe Haven Site, a small gene-free region. Contains NEO resistance marker.
    Depositor
    Type
    Empty backbone
    Use
    Cryptococcal complementation vector
    Promoter
    ACT1 for Cryptococcal marker
    Available Since
    Oct. 9, 2015
    Availability
    Academic Institutions and Nonprofits only
  2. pSDMA25

    Plasmid
    #67940
    Purpose
    Complementation in Cryptococcus neoformans. Targets DNA constructs to a Safe Haven Site, a small gene-free region. Contains nourseothricin resistance marker (NAT)
    Depositor
    Type
    Empty backbone
    Use
    Cryptococcal complementation vector
    Promoter
    ACT1 for Cryptococcal marker
    Available Since
    Oct. 9, 2015
    Availability
    Academic Institutions and Nonprofits only
  3. pSDMA58

    Plasmid
    #67942
    Purpose
    Complementation in Cryptococcus neoformans. Targets DNA constructs to a Safe Haven Site, a small gene-free region. Contains HYG resistance marker.
    Depositor
    Type
    Empty backbone
    Use
    Cryptococcal complementation vector
    Promoter
    ACT1 for Cryptococcal marker
    Available Since
    Oct. 9, 2015
    Availability
    Academic Institutions and Nonprofits only
  4. pSDMA66

    Plasmid
    #128355
    Purpose
    gRNA ribozyme construct with Cryptococcus neoformans ACT1 promter and TRP1 terminator. Following ribozyme cleavage, a gRNA targeting ADE2 is liberated.
    Depositor
    Insert
    Noureothricin (NAT)
    Use
    Unspecified
    Promoter
    ACT1
    Available Since
    Aug. 20, 2019
    Availability
    Academic Institutions and Nonprofits only
  5. pSDMA67

    Plasmid
    #128356
    Purpose
    gRNA ribozyme construct with Cryptococcus neoformans ACT1 promter and TRP1 terminator. Following ribozyme cleavage, a gRNA targeting ADE2 is liberated.
    Depositor
    Insert
    Noureothricin (NAT)
    Use
    Unspecified
    Promoter
    ACT1
    Available Since
    Aug. 13, 2020
    Availability
    Academic Institutions and Nonprofits only
Showing: 1 - 30 of 307 results